EDMONTON, Alberta, Sept. 11 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pink Sheets: MSITF) wishes to announce that it has completed testing with its VScan HIV test kit and the VScan Hepatitis C test kit in Europe. Completion of this testing will allow it to apply for EU approval of both test kits.
EU approval would allow the Company to expand its distribution network with the initial setup of 10 distributors in Europe. It is anticipated that when EU approval is received that it will result in the sale of up to 1.0 million (gross sales of $2,000,000USD) test kits in the first year. It is believed based on studies completed that this will be a very active market with rapid growth potential. Once approval is received the Company expects to also market the kits through an independent internet site
The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV1&2, Hepatitis B&C, Tuberculosis (TB), Malaria, Dengue Fever, West Nile, Syphilis and Prostate Cancer.
Medical Services International Inc. trades in the United States on the NQB Pink Sheets under the symbol "MSITF". For further information, please contact Robert Talbot at 780 430 6363 or http://www.medicalservicesintl.com or http://www.minerva-biotech.com.
NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies
|SOURCE Medical Services International Inc.|
Copyright©2007 PR Newswire.
All rights reserved